Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
The Lancet Regional Health. Europe|April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based studyKatie Bechman, Mark D Russell, Kathryn Biddle, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2026
Substituent-Based Modulation of Self-Assembly and Immunogenicity of Amphipathic PeptidesAnirban Das, Ushasi Pramanik, Elise M Brown, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Experimental Gerontology|April 3, 2003
mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the IrishOwen A Ross, Rose McCormack, Lynn D Maxwell, et al.
Parkinsonism & Related Disorders|August 17, 2005
Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PDDavid Gosal, Owen A Ross, Joe Wiley, et al.
Annals of the Rheumatic Diseases|July 10, 2026
Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTsMark Gibson, Victoria Allen, Maryam Adas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
Neuroscience Letters|May 12, 2009
Phactr2 and Parkinson's diseaseChristian Wider, Sarah J Lincoln, Michael G Heckman, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Pageof 12